/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

Y

Yoshikazu Miyasato

Kumamoto University Hospital(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

49

Papers

328

Citations

10

h-index

11

i10-index

Yoshikazu Miyasato is an academic researcher from Kumamoto University Hospital. The author has contributed to research in topics: Dialysis and Renal Disease Management & Renal Diseases and Glomerulopathies & Chronic Kidney Disease and Diabetes. The author has an h-index of 10, co-authored 42 publications.

Research Topics

Dialysis and Renal Disease Management Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Ion Transport and Channel Regulation Electrolyte and hormonal disorders

Papers by this author

works

Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response

2018 · Scientific Reports · 66 citations

https://doi.org/10.1038/s41598-018-24257-7

Yoshikazu Miyasato Tatsuya Yoshizawa Yoshifumi Sato Terumasa Nakagawa

Liddle’s-like syndrome associated with nephrotic syndrome secondary to membranous nephropathy: the first case report

2018 · BMC Nephrology · 18 citations

https://doi.org/10.1186/s12882-018-0916-3

Eriko Yamaguchi Kazuhiro Yoshikawa Izaya Nakaya Karen Kato

Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model

2016 · Journal of Pharmacological Sciences · 13 citations

https://doi.org/10.1016/j.jphs.2016.01.003

Yuki Narita Miki Ueda Kohei Uchimura Yutaka Kakizoe

A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats

2021 · Journal of Pharmacological Sciences · 7 citations

https://doi.org/10.1016/j.jphs.2021.04.003

Teruhiko Mizumoto Yutaka Kakizoe Terumasa Nakagawa Yasunobu Iwata

Camostat mesilate, a serine protease inhibitor, exerts aquaretic effects and decreases urinary exosomal AQP2 levels

2022 · Journal of Pharmacological Sciences · 1 citations

https://doi.org/10.1016/j.jphs.2022.09.003

Yutaka Kakizoe Terumasa Nakagawa Yasunobu Iwata Qinyuan Deng

WCN25-275 A CASE OF THROMBOTIC MICROANGIOPATHY IN LUPUS NEPHRITIS FOLLOWING TREATMENT WITH MOGAMULIZUMAB, ANTI-CCR4 ANTIBODY, FOR ADULT T CELL LEUKEMIA

2025 · Kidney International Reports · 1 citations

https://doi.org/10.1016/j.ekir.2024.11.213

Yoshikazu Miyasato Takashige Kuwabara K Yamada Koki Matsushita

Research topics

topics

Dialysis and Renal Disease Management

Renal Diseases and Glomerulopathies

Chronic Kidney Disease and Diabetes

Ion Transport and Channel Regulation

Electrolyte and hormonal disorders

Chat about Author

Papers

Chat

Click to start Chat